Welcome to our dedicated page for 3M SEC filings (Ticker: MMM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The 3M Company (NYSE: MMM) SEC filings page on Stock Titan provides structured access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a multinational manufacturing conglomerate with shares listed on the New York Stock Exchange and also traded on the SIX Swiss Exchange, 3M files a range of reports with the U.S. Securities and Exchange Commission that detail its financial condition, risk factors, governance, and capital structure.
Investors researching MMM can use this page to review current reports on Form 8-K, which 3M uses to disclose material events such as quarterly financial results, updates to full-year guidance, and changes in board composition. For example, 3M has filed Form 8-K reports to furnish third-quarter financial results and to note the retirement of a director from its board. These filings complement the company’s earnings press releases and provide official regulatory context.
In addition to 8-Ks, users can access annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for Safety and Industrial, Transportation and Electronics, and Consumer, as well as discussions of legal proceedings, portfolio changes such as the spin-off of the healthcare business into Solventum, and other matters affecting 3M’s operations. Proxy statements and related documents describe board structure and governance practices, while registration statements and debt-related filings outline securities such as notes due in various years.
Stock Titan enhances these filings with AI-generated highlights and explanations, helping readers quickly identify key topics like revenue trends, margin changes, litigation-related disclosures, and capital allocation. Real-time updates from EDGAR mean new MMM filings appear promptly, and users can also review insider-related filings such as Form 4 to track transactions by directors and officers. This combination of raw documents and AI analysis allows investors, researchers, and other stakeholders to navigate 3M’s regulatory record more efficiently.
3M executive Zoe L. Dickson, EVP & Chief HR Officer, reported equity transactions on February 6, 2026. Dickson converted 4,764 restricted stock units into the same number of 3M common shares at an exercise price of $0, reflecting vesting of a prior equity grant.
On the same date, 1,500 common shares were disposed of at $172.65 per share in a transaction coded "F," indicating shares withheld to cover taxes in connection with the vesting. After these transactions, Dickson directly beneficially owned 21,123.4401 shares of common stock and indirectly held 299 shares through a 401k/PAESOP trust.
The filing notes that each restricted stock unit represents a contingent right to receive one share of 3M common stock and that the RSUs involved in this transaction vest 100% three years from their grant date of February 7, 2023, aligning with 3M’s deferred compensation and equity incentive arrangements.
3M Group President Beatriz Karina Chavez Rodriguez reported insider transactions dated February 6, 2026. She exercised 6,887 restricted stock units, each converting into one share of 3M common stock, and acquired the same number of common shares at $172.65 per share.
On the same date, she disposed of 2,307 common shares at $172.65 per share, coded as transaction type F. Following these transactions, she directly beneficially owned 18,839.3048 common shares, with a separate reported direct holding of 2,209.385 shares. The derivative position in these restricted stock units decreased to zero after the exercise.
3M Executive Vice President John Patrick Banovetz reported routine equity compensation activity. On February 6, 2026, 4,818 restricted stock units converted into the same number of 3M common shares at an exercise price of $0, reflecting previously granted stock-based compensation that vested three years after the February 7, 2023 grant.
On the same day, 1,362 common shares were withheld or sold at $172.65 under transaction code “F,” typically used for tax withholding on vesting. After these transactions, Banovetz directly held 42,971.1246 shares of 3M common stock, including dividend equivalents and shares from company plans.
3M is reporting a planned insider sale of common stock under Rule 144. The notice covers 1,190 common shares with an aggregate market value of 203644.82 to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/09/2026.
The shares were acquired over several years through the employee stock purchase plan and restricted stock vesting, including 411 shares that vested on 02/08/2025. Common shares outstanding are listed as 526700000, providing context for the relatively small size of this planned sale.
An insider of the issuer has filed a notice of intent to sell 45,574 common shares through Fidelity Brokerage Services LLC on February 9, 2026, with an aggregate market value of $7,753,518.25 and the shares listed on the NYSE.
The shares to be sold were acquired on February 9, 2026 by exercising options originally granted on February 7, 2023 and February 8, 2022 for 25,055 and 20,519 shares, respectively, paid in cash. The issuer had 526,700,000 shares outstanding. During the prior three months, the same account holder, Zoe Dickson, sold 27,455 common shares for gross proceeds of $4,661,910.00.
3M Company insider Victoria Clarke has filed a notice of proposed stock sales under Rule 144. The filing covers 4,137 shares of common stock with an aggregate market value of
The 4,137 shares were acquired on
3M executive Zoe L. Dickson reported equity compensation activity in 3M common stock. On February 2, 2026, she was credited with 11,964.32 shares at $0 per share under a performance share award granted on March 1, 2023, after performance goals were certified.
She previously elected to defer receipt of these shares and will not have voting or investment power over them until they are issued. On the same date, 282 shares were withheld at $0 to cover estimated taxes. After these transactions, she beneficially owns 17,859.4401 shares directly and 299 shares indirectly through a 401k/paesop trust.
3M executive Kevin H. Rhodes reported equity compensation activity tied to performance share awards. On February 2, 2026, he acquired 23,251.392 shares of 3M common stock at $0 per share when performance-based vesting requirements for awards granted on March 1, 2023 were certified as achieved.
On the same date, 4,732 shares were withheld, at $0, to cover taxes, leaving him with 33,738.3379 shares of 3M common stock held directly. Half of the vested shares were deferred, and he will not have voting or investment power over those deferred shares until they are issued.
3M Group President Beatriz Karina Chavez Rodriguez reported equity compensation activity in 3M common stock. On February 2, 2026, she acquired 8,650.304 shares at $0 under a performance share award granted on March 1, 2023, after performance goals were certified as achieved.
On the same date, 3,945 shares were withheld at $0 to cover estimated taxes related to this award. Following these transactions, she directly held 14,259.3048 shares of common stock, and a separate holding line reflects 2,209.385 shares, which includes dividend share equivalents accrued under 3M's Deferred Compensation Plan.